SALK NACHRICHTEN

Salk Institut für Biologische Studien - SALK NACHRICHTEN

Salk Nachrichten


Salk Institute Molekularbiologe Inder M. Verma zum Chefredakteur von PNAS ernannt

WASHINGTON, DC—Die National Academy of Sciences (NAS) gibt die Ernennung von bekannt Inder M. Verma, Ph.D., als Chefredakteur des Proceedings of the National Academy of Sciences (PNAS), der offiziellen Zeitschrift der NAS. Er wird die Chefredaktion am 1. November formell übernehmen, und der Übergang in die neue Position wird sich über mehrere Wochen erstrecken.


Salk erweckt den Kampf gegen die häufigste Todesursache von Frühgeborenen zu neuem Leben.

LA JOLLA, CA – Eine Entdeckung von Wissenschaftlern am Salk Institute for Biological Studies könnte erklären, warum einige Frühgeborene auf bestehende Behandlungen für ein tödliches Atemnotsyndrom (RDS) nicht ansprechen, und liefert Hinweise auf neue Behandlungsmöglichkeiten für die Atemwegserkrankung.


Salk Institute earns top global ranking for scientific research

LA JOLLA, CA—The SCImago Institutions Rankings (SIR) World Report has identified the Salk Institute as one of the top five research organizations in the world, based on excellence and high quality of its scientific findings.


Salk to accelerate brain research with $4.5 million NIH grant

LA JOLLA—The National Institutes of Health has announced that the Salk Institute will receive $4.5 million to establish a Neuroscience Core Center, a new research center intended to accelerate brain research that lays the foundation for developing new ways to treat congenital brain defects and neurological diseases.


“Alarm clock” gene explains wake-up function of biological clock

LA JOLLA, CA‚Ever wondered why you wake up in the morning—even when the alarm clock isn’t making jarring noises? Wonder no more. Researchers at the Salk Institute for Biological Studies have identified a new component of the biological clock, a gene responsible for starting the clock from its restful state every morning.


Salk-Wissenschaftler erhält renommierten NIH-Preis für transformative Forschung

LA JOLLA, CA—Dr. Fred Gage, ein Professor am Salk Institute Laboratory of Genetics und Inhaber des Vi and John Adler Chair for Research on Age-Related Neurodegenerative Diseases, wurde als Preisträger des renommierten Programms „National Institutes of Health (NIH) Director’s Transformative Research Projects (T-R01)“ für 2011 ausgezeichnet.


Discovery of insulin switches in pancreas could lead to new diabetes drugs

LA JOLLA, CA—Researchers at the Salk Institute have discovered how a hormone turns on a series of molecular switches inside the pancreas that increases production of insulin.


Bionic bacteria may help fight disease and global warming

La Jolla—A strain of genetically enhanced bacteria developed by researchers at the Salk Institute for Biological Studies may pave the way for new synthetic drugs and new ways of manufacturing medicines and biofuels, according to a paper published September 18 in Nature Chemical Biology.


Salk scientist earns competitive grant from Whitehall Foundation

LA JOLLA, CA—Axel Nimmerjahn, Ph.D., assistant professor in the Waitt Advanced Biophotonics Center and holder of the Richard Allan Barry Developmental Chair in Biophotonics has been awarded a highly selective grant from the Whitehall Foundation. He will receive $223,000.00 over three years to study the contribution of astrocytes to normal brain function.


Sind Gene unser Schicksal?

LA JOLLA, CA – Ein “versteckter” Code, der mit der DNA von Pflanzen verbunden ist, ermöglicht es ihnen, neue biologische Merkmale weitaus schneller zu entwickeln und weiterzugeben, als bisher angenommen, so die Ergebnisse einer bahnbrechenden Studie von Forschern des Salk Institute for Biological Studies.


First proof in patients of an improved “magic bullet” for cancer detection and radio-therapy

LA JOLLA, CA—Oncologists have long sought a powerful “magic bullet” that can find tumors wherever they hide in the body so that they can be imaged and then destroyed. Until recently scientists accepted the notion that such an agent, an agonist, needed to enter and accumulate in the cancerous cells to act. An international research team has now shown in cancer patients that an investigational agent that sticks onto the surface of tumor cells without triggering internalization, an antagonist, may be safer and even more effective than agonists.


Salk-Ergebnisse könnten Ärzten eine Möglichkeit geben, Krebs früher zu erkennen

LA JOLLA, CA—Mehr als 230.000 Frauen in den Vereinigten Staaten werden in diesem Jahr mit Brustkrebs diagnostiziert, von denen fast 10% Mutationen in den Genen BRCA1 oder 2 aufweisen werden. Es ist bekannt, dass das BRCA1-Gen und sein Protein eine wichtige Rolle bei der Verhinderung der Entstehung von Brust- und Eierstockkrebs spielen, aber wie genau sie dies tun, war lange Zeit ein umstrittenes, ja sogar kontroverses Thema. Nun wurde in der Ausgabe vom 8. September des Natur, Forscher des Salk Institute haben möglicherweise eine Antwort gefunden – und diese deutet darauf hin, dass die bisherigen unterschiedlichen vorherrschenden Theorien allesamt ein wenig richtig lagen.


The battle of the morphogens: How to get ahead in the nervous system

LA JOLLA, CA—If you think today’s political rhetoric is overheated, imagine what goes on inside a vertebrate embryo. There, two armies whose agendas are poles apart, engage in a battle with consequences much more dire than whether the economy will recover—they are battling for whether you (or frogs or chickens) will have a forebrain.


Gleeful Performance by Broadway Star Idina Menzel at 16th Annual Symphony at Salk

Perched high above the Pacific Ocean, under a canopy of stars, the iconic courtyard was transformed into an enchanting concert venue for the 16th annual Symphony at Salk.


Alaskan family keeps pioneering spirit alive donating $1.6 million to Salk Institute

LA JOLLA, CA—The Salk Institute for Biological Studies today announced a generous $1.6 million dollar gift from the estate of Henry and Lottie O’Neal of Anchorage, Alaska. Their substantial donation will help continue the pioneering research conducted at the Salk Institute.


Salk Institute named global leader in plant biology research

LA JOLLA, CA—Thomson Reuters Essential Science Indicators has seeded the Salk Institute as the number one research organization for plant biology in the world.


A funny thing happened on the way to summer…

La Jolla—Our next generation of Scientists have arrived. Salk’s high school scholars – students from around San Diego County – gather at the Institute every summer to participate in hands-on laboratory experiences under the mentorship of a Salk scientist. The young scientists will present their findings today during the “Summer Research Presentations” event at 1:00 pm in the Trustees Room at the Salk Institute.


Scientists take a giant step for people – with plants!

La Jolla—Science usually progresses in small steps, but on rare occasions, a new combination of research expertise and cutting-edge technology produces a ‘great leap forward.’ An international team of scientists, whose senior investigators include Salk Institute plant biologist Joseph Ecker, report one such leap in the July 29, 2011 issue of Science. They describe their mapping and early analyses of thousands of protein-to-protein interactions within the cells of Arabidopsis thaliana -a variety of mustard plant that is to Pflanzenbiologie what the lab mouse is to human biology.


Salk researchers develop method to map cell receptor that regulates stress

LA JOLLA, CA—Drug developers have long been looking for agents that will target a cell receptor that regulates stress in humans, but no small molecule drugs have successfully gone through clinical studies. Now, a team at the Salk Institute has demonstrated how a novel tool can be used to map the binding sites on this receptor, which they say could speed the design of effective therapies.


New technique boosts efficiency of blood cell production from human stem cells

LA JOLLA, CA—Scientists at the Salk Institute for Biological Studies have developed an improved technique for generating large numbers of blood cells from a patient’s own cells. The new technique will be immediately useful in further stem cell studies, and when perfected, could be used in stem cell therapies for a wide variety of conditions including cancers and immune ailments.